Australia markets closed

Twist Bioscience Corp (0ME.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
23.89-0.66 (-2.69%)
At close: 08:15AM CET
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/09/2022
30/09/2021
30/09/2020
30/09/2019
Total revenue
203,565
203,565
132,333
90,100
54,385
Cost of revenue
119,330
119,330
80,620
61,406
47,426
Gross profit
84,235
84,235
51,713
28,694
6,959
Operating expenses
Research development
120,307
120,307
69,072
43,006
35,683
Selling general and administrative
212,949
212,949
135,901
103,267
80,126
Total operating expenses
333,256
333,256
204,973
146,273
115,809
Operating income or loss
-249,021
-249,021
-153,260
-117,579
-108,850
Interest expense
80
80
367
787
1,294
Total other income/expenses net
17,765
17,765
-836
-22,682
-265
Income before tax
-228,274
-228,274
-154,028
-139,549
-107,377
Income tax expense
-10,411
-10,411
-1,930
382
292
Income from continuing operations
-217,863
-217,863
-152,098
-139,931
-107,669
Net income
-217,863
-217,863
-152,098
-139,931
-107,669
Net income available to common shareholders
-217,863
-217,863
-152,098
-139,931
-107,669
Basic EPS
-
-
-3.15
-3.57
-3.92
Diluted EPS
-
-
-3.15
-3.57
-3.92
Basic average shares
-
-
48,251
39,190
27,462
Diluted average shares
-
-
48,251
39,190
27,462
EBITDA
-
-211,680
-143,911
-132,085
-99,972